Kuros Biosciences, a leader in next-generation bone graft technologies, announced that it will report its full-year financial results and provide a corporate update on its business on March 13, 2024.
Kuros Biosciences, a leader in next-generation bone graft technologies, announced that it will report its full-year financial results and provide a corporate update on its business on March 13, 2024.